Stocknear Logo Stocknear
/
Popular
Login

Ligand Pharmaceuticals

99.56
-4.28 (-4.13%)
At close: Apr 10, 2025, 1:30 PM

Ligand Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-4.03M 52.15M -33.36M 57.14M -2.98M 629.3M 143.32M 12.56M -2.37M
33.91M 35.64M 51.37M 50.95M 27.97M 43.73M 14.72M 11.71M 11.29M
41.09M 25.74M 60.28M 38.78M 30.73M 24.52M 20.85M 24.91M 18.89M
n/a -16.23M 1.64M -21.95M 35.04M -9.57M -2.21M -524K 518K
26.08M -41.26M -26.84M -7.29M 28M -797.5M 24.29M 11.3M 35.11M
n/a 11.7M 20.72M -8.62M -19.05M 74.83M 29.74M 44.52M 10.7M
n/a -34.4M 65.68M -52.16M -10.06M -4.21M -38.85M -11.44M -10.62M
97.05M 49.58M 137.85M 78.8M 54.59M -29.34M 194.06M 93.57M 63M
-1.82M -3.52M -17.92M -8.76M -4.46M -2.55M -11.89M -7.15M -28.32M
-92M -10.4M -750K 494K -383.32M -12.84M -5.86M -26.65M -94.2M
-200.6M -142.01M -51.23M -181.32M -422.52M -2.36B -1.43B -254.26M -164.44M
262.5M 194.17M 234.39M 221.34M 1.04B 2.03B 1.02B 196.63M 143.47M
-111.75M -49.91M -868K -1.22M 3.26M 808.13M 3.91M 7.25M 300K
-143.66M -11.68M 163.62M 30.52M 231.65M 466.92M -423.27M -84.18M -143.19M
-25K -76.9M -261M -146.01M -231.76M -27.32M 532.33M n/a n/a
n/a -4.55M -8.24M -18.45M -78M -453.05M -122.87M -1.97M -3.9M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
60.03M 16.95M -6.75M 8.25M -789K -383K -77.11M -5.56M -999K
97.14M -59.95M -275.99M -137.76M -310.55M -485.17M 328.58M -7.52M 1.51M
49.35M -22.05M 25.48M -28.44M -24.31M -47.51M 99.16M 1.87M -78.68M
95.23M -4.27M 119.93M 70.04M 50.13M -31.89M 182.17M 86.41M 34.68M

Create Price Alert on LGND

Your price alert will notify you when the stock price is above 99.56.

Add to Watchlist